Zacks Research Brokers Decrease Earnings Estimates for A

Agilent Technologies, Inc. (NYSE:A) – Equities research analysts at Zacks Research cut their Q2 2026 earnings per share (EPS) estimates for Agilent Technologies in a research report issued to clients and investors on Monday, February 24th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $1.46 per share for the quarter, down from their prior estimate of $1.47. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.56 per share.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%.

A has been the topic of a number of other reports. JPMorgan Chase & Co. lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $135.00 to $145.00 in a report on Monday, February 10th. Robert W. Baird dropped their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Bank of America dropped their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Stock Performance

Shares of A opened at $127.07 on Thursday. The stock has a market cap of $36.25 billion, a price-to-earnings ratio of 28.75, a PEG ratio of 3.63 and a beta of 1.07. Agilent Technologies has a 52 week low of $124.16 and a 52 week high of $155.35. The business has a 50-day simple moving average of $140.78 and a two-hundred day simple moving average of $139.20. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57.

Hedge Funds Weigh In On Agilent Technologies

Several institutional investors and hedge funds have recently bought and sold shares of the stock. CKW Financial Group lifted its stake in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. increased its stake in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after buying an additional 116 shares during the period. Redwood Park Advisors LLC acquired a new position in shares of Agilent Technologies during the fourth quarter valued at approximately $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies in the 4th quarter worth $29,000. Finally, Sunbelt Securities Inc. raised its position in Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock worth $30,000 after acquiring an additional 192 shares in the last quarter.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.